Thursday, August 5, 2021
ADVT 
Interesting

Heart woes spur partial stop of malaria drug study for virus

Darpan News Desk The Canadian Press, 13 Apr, 2020 07:37 PM

    Scientists in Brazil have stopped part of a study of a malaria drug touted as a possible coronavirus treatment after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested.

    Chloroquine and a newer, similar drug called hydroxychloroquine, have been pushed by President Donald Trump after some very small, early tests suggested the drugs might curb the virus from entering cells. But the drugs have long been known to have potentially serious side effects, including altering the heartbeat in a way that could lead to sudden death.

    The Brazilian study, in the Amazonian city of Manaus, had planned to enrol 440 severely ill COVID-19 patients to test two doses of chloroquine, but researchers reported results after only 81 had been treated.

    One-fourth of those assigned to get 600 milligrams twice a day for 10 days developed heart rhythm problems, and trends suggested more deaths were occurring in that group, so scientists stopped that part of the study.

    The other group was given 450 milligrams twice a day on the first day then once a day for four more days. That is closer to what’s being tried in some other studies including some in the United States. It’s too soon to know whether that will prove safe or effective; the Brazil study had no comparison group that was getting no treatment.

    Only one participant in the Brazil study had no signs of the virus in throat swabs after treatment, researchers noted.

    The results from the Brazil study were posted on a research website and have not yet been reviewed by other scientists.

    Complicating matters is that all patients in the study also received two antibiotics, ceftriaxone and azithromycin. The latter also can have side effects on the heart. Trump has touted the hydroxychloroquine-azithromycin combination.

    Brazil’s President Jair Bolsonaro has repeatedly touted the benefits of chloroquine and azithromycin without evidence. He said at one point he heard reports of 100% effectiveness when administered in the correct dosages, zeroed tariffs for import of the drugs, and late last month announced military labs were ramping up their chloroquine production.

    MORE Interesting ARTICLES

    A look at COVID-19 in depth for Canada and around the world

    COVID-19 measures and a rush on wills as well as globally how countries are tackling the CoronaVirus. 

    A look at COVID-19 in depth for Canada and around the world

    Busy weekend for small wildfires in B.C.

    The BC Wildfire Service lists the fire danger rating across most of the province as low to moderate but firefighters in several regions still had a busy Easter weekend.The wildfire service website shows crews responded to 11 blazes between Good Friday and Easter Sunday.

    Busy weekend for small wildfires in B.C.

    Maharaja Ranjit Singh: The Lion of Punjab

    Maharaja Ranjit Singh: The Lion of Punjab

    He unified the warring chiefdoms of the Punjab into a powerful northern Empire of the Sikhs stretching to the borders of Afghanistan and Tibet

    Maharaja Ranjit Singh: The Lion of Punjab

    The Battle of Saragarhi

    The Battle of Saragarhi

    The Battle of Saragarhi was fought between 21 Sikhs soldiers of the 31st Sikh Regiment of the British Indian Army, and about 10,000 Afghan tribesmen on September 12, 1897

    The Battle of Saragarhi

    What to know about malaria drug and coronavirus treatment

    Some politicians and doctors are sparring over whether to use hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it now.

    What to know about malaria drug and coronavirus treatment

    Application process for emergency benefits for workers begins this morning

    Application process for emergency benefits for workers begins this morning

    OTTAWA — Applications open today for the new federal emergency aid benefit for Canadians who lost their income because of COVID-19.

    Application process for emergency benefits for workers begins this morning

    PrevNext